InterMune, Inc. Reports First Quarter 2014 Financial Results, Clinical Development And Business Highlights

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BRISBANE, Calif., May 1, 2014 /PRNewswire/ -- InterMune, Inc. (NASDAQ: ITMN) today announced results from operations for the first quarter ended March 31, 2014. The company also highlighted recent clinical development and business highlights, and raised its forward-looking revenue guidance for 2014.

Help employers find you! Check out all the jobs and post your resume.

Back to news